Evidence map›Paper›PMID 41961180›Full record

ReviewCurrent neurology and neuroscience reports2026

Redefining Stroke Care with Artificial Intelligence: Recent Advances.

Shivi Mendiratta, Mark Parsons, Carlos Garcia-Esperon, Amit Mehndiratta

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current neurology and neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shivi MendirattaCentre for Biomedical Engineering, Indian Institute of Technology Delhi (IITD), New Delhi, India.ORCID 0009-0004-3038-4268
Mark ParsonsUniversity of New South Wales (UNSW), Sydney, Australia.ORCID 0000-0001-8874-2487
Carlos Garcia-EsperonCollege of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, Australia. carlos.garciaesperon@health.nsw.gov.au.ORCID 0000-0001-8843-5890
Amit MehndirattaCentre for Biomedical Engineering, Indian Institute of Technology Delhi (IITD), New Delhi, India. amit.mehndiratta@keble.oxon.org.ORCID 0000-0001-6477-2462

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review aims to provide an overview of how artificial intelligence (AI) is being integrated into stroke care across the full clinical spectrum with emphasis on its applications in diagnosis, management, and rehabilitation. The focus is on recent advances (2020–2025), addressing key questions on clinical utility and implementation challenges. RECENT

findingsAI has shown promise in enhancing stroke diagnosis through imaging analysis, wearable sensors, and remote monitoring. In stroke management, it supports decision-making and therapy optimization. AI-enabled tools are also improving rehabilitation via robotics and computer vision, and aid prevention through risk prediction and community screening. However, challenges remain in model generalizability, acceptance by the community, and ethical concerns. AI is reshaping stroke care by enabling personalized, timely, and data-driven approaches which can significantly improve quality of life. Future progress will depend on transparent multimodal, globally validated models, supported by interdisciplinary collaboration.

Indexed as

Artificial IntelligenceStrokeStroke RehabilitationHumansArtificial IntelligenceClinical decision supportNeuroimagingPrecision medicineRehabilitationStroke

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.